Skip to main content

The Globe and Mail

Illumina Inc (ILMN-Q) Quote

Unchecking box will stop auto data updates
Cboe BZX Real-Time Last Sale USD
Today's Change
Price Quote as of

Today's Trading

Day Low 240.13
Day High 243.90
Price movement based on the high, low and last over the given period.
Previous Close
Average Volume
Price/Earnings (TTM)
Trailing Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Illumina, Inc. is improving human health by unlocking the power of the genome. Their focus on innovation has established them as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. The Company's products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company's sequencing by synthesis technology provides researchers with various applications and the ability to sequence mammalian genomes. It also offers arrays for a range of deoxyribonucleic acid and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis, as well as allow for the detection of known genetic markers on a single array.


Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share ttm
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings ttm
Trailing Annual Dividend & Yield
Ex-Div Date
Forward P/E
Most Recent Split


Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

73.3% Return Seen to Date on SmarTrend Illumina Inc Call (ILMN)
Comtex SmarTrend(R) - Wed Jan 17, 11:09PM CST
Comtex SmarTrend(R) - CMTX
Wed Jan 17, 11:09PM CST
SmarTrend identified an Uptrend for Illumina Inc (NASDAQ:ILMN) on January 6th, 2017 at $139.64. In approximately 13 months, Illumina Inc has returned 73.34% as of today's recent price of $242.05.
Illumina to Announce Fourth Quarter and Fiscal Year 2017 Financial Results on Tuesday, January 30, 2018
BusinessWire - Tue Jan 16, 8:00AM CST
BusinessWire - CMTX
Tue Jan 16, 8:00AM CST
Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for fourth quarter and fiscal year 2017 following the close of market on Tuesday, January 30, 2018.
Luna DNA Announces Dawn Barry, former Illumina VP, as President
PR Newswire - Mon Jan 15, 9:00AM CST
PR Newswire - CMTX
Mon Jan 15, 9:00AM CST
Luna DNA, the first and only genomic and medical research knowledge base powered by the blockchain and owned by its community, announced today Dawn Barry as president. In this role, Barry will be responsible for leading operations, communicating and implementing company mission, and guiding overall strategy, direction, and growth.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 210.37 +14.71% increase
on 12/19/17
Period Open:217.29
Price movement based on the high, low and last over the given period.
248.97 -3.08% decrease
on 01/16/18
+24.02 (+11.05%) increase
since 12/18/17
3-Month 198.21 +21.74% increase
on 10/25/17
Period Open:205.62
Price movement based on the high, low and last over the given period.
248.97 -3.08% decrease
on 01/16/18
+35.69 (+17.36%) increase
since 10/18/17
52-Week 156.50 +54.19% increase
on 02/01/17
Period Open:161.23
Price movement based on the high, low and last over the given period.
248.97 -3.08% decrease
on 01/16/18
+80.08 (+49.67%) increase
since 01/18/17

All market data is provided by Barchart Solutions (will open in new tab). Copyright © 2018.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

More stories below advertisement